How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In the high-tech, high-competition AI field, we are seeing new versions of models rolled out by the frontier companies (OpenAI, Google and Anthropic) every month and a half. I included a Release ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Coding agents can improve by changing the prompts, tools and code that guide their work. But finding which changes actually help and are worth preserving is challenging and expensive. Each candidate ...

Donald Trump says “everything is falling” as he argues that inflation, oil prices and other costs are moving in the right direction. David Pakman examines the distinction between inflation slowing and ...